Darren Howard Smith, CFO of S. African Subsidiary at Sonnet BioTherapeutics Holdings, holds 811.00 shares in Sonnet BioTherapeutics Holdings (Ticker: SONN). Most recently, Darren Howard Smith Bought $435 shares of Sonnet BioTherapeutics Holdings on Dec 29, 2014 for an estimated value of 652.50.